Patient perspectives on depot buprenorphine treatment for opioid addiction - a qualitative interview study.

ABSTRACT:

Background

Recently developed buprenorphine depot injections have the potential to reduce risk for diversion and misuse, and to increase adherence with fewer visits for supervised intake. However, it is unclear how patients perceive this new form of medication. The purpose of this study was to explore patients' experiences of depot injections and their reasons for continuing, discontinuing, or declining depot injection treatment.

Methods

We conducted semi-structured qualitative interviews with 32 people, 14 of whom had ongoing depot injection treatment, 11 who had discontinued depot-injections and switched to other medication and seven who had declined treatment with depot formulations. Interviews were transcribed, coded, and analysed using NVivo, based on this overall strat

SUBMITTER: Johnson B 

PROVIDER: S-EPMC9131643 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature